120 related articles for article (PubMed ID: 9935145)
1. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
Hagensee ME; Kiviat N; Critchlow CW; Hawes SE; Kuypers J; Holte S; Galloway DA
J Infect Dis; 1997 Sep; 176(3):625-31. PubMed ID: 9291307
[TBL] [Abstract][Full Text] [Related]
3. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of human papillomavirus type 16 in pregnant women.
Hagensee ME; Slavinsky J; Gaffga CM; Suros J; Kissinger P; Martin DH
Obstet Gynecol; 1999 Nov; 94(5 Pt 1):653-8. PubMed ID: 10546705
[TBL] [Abstract][Full Text] [Related]
6. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
[TBL] [Abstract][Full Text] [Related]
7. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.
Carter JJ; Koutsky LA; Wipf GC; Christensen ND; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 1996 Nov; 174(5):927-36. PubMed ID: 8896492
[TBL] [Abstract][Full Text] [Related]
8. Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller JT; Forsgren M; Dillner J
Int J Cancer; 1998 May; 76(3):341-4. PubMed ID: 9579570
[TBL] [Abstract][Full Text] [Related]
9. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.
Lagergren J; Wang Z; Bergström R; Dillner J; Nyrén O
J Natl Cancer Inst; 1999 Jan; 91(2):156-62. PubMed ID: 9923857
[TBL] [Abstract][Full Text] [Related]
11. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.
Olsen AO; Dillner J; Gjøen K; Magnus P
Genitourin Med; 1997 Apr; 73(2):131-5. PubMed ID: 9215097
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of human papillomavirus type 16 antibody seroconversion in young children.
Manns A; Strickler HD; Wikktor SZ; Pate EJ; Gray R; Waters D
Pediatr Infect Dis J; 1999 Sep; 18(9):833-5. PubMed ID: 10493350
[No Abstract] [Full Text] [Related]
15. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
[TBL] [Abstract][Full Text] [Related]
16. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.
Strickler HD; Kirk GD; Figueroa JP; Ward E; Braithwaite AR; Escoffery C; Drummond J; Goebel B; Waters D; McClimens R; Manns A
Int J Cancer; 1999 Jan; 80(3):339-44. PubMed ID: 9935171
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
19. Type-specific antiviral antibodies to genital human papillomavirus types in mothers and newborns.
Heim K; Hudelist G; Geier A; Szedenik H; Christensen ND; Concin N; Bergant A; Volgger B; Czerwenka K; Höpfl R
Reprod Sci; 2007 Dec; 14(8):806-14. PubMed ID: 18089599
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]